NKTX
Price
$2.79
Change
-$0.18 (-6.06%)
Updated
Jul 13 closing price
Capitalization
199.61M
23 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.30
Change
-$0.26 (-7.30%)
Updated
Jul 13 closing price
Capitalization
1.75B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NKTX vs RXRX

NKTX vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
NKTX vs. RXRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (NKTX: $2.79 vs. RXRX: $3.30)
Brand notoriety: NKTX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 59% vs. RXRX: 94%
Market capitalization -- NKTX: $199.61M vs. RXRX: $1.75B
NKTX [@Biotechnology] is valued at $199.61M. RXRX’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • NKTX’s TA Score: 5 bullish, 5 bearish.
  • RXRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than RXRX.

Price Growth

NKTX (@Biotechnology) experienced а -15.45% price change this week, while RXRX (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

NKTX is expected to report earnings on Aug 06, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.75B) has a higher market cap than NKTX($200M). NKTX YTD gains are higher at: 50.811 vs. RXRX (-19.315). NKTX has higher annual earnings (EBITDA): -107.08M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. NKTX (230M). RXRX (72.4M) and NKTX (75M) have identical debt. RXRX has higher revenues than NKTX: RXRX (65.7M) vs NKTX (0).
NKTXRXRXNKTX / RXRX
Capitalization200M1.75B11%
EBITDA-107.08M-478.66M22%
Gain YTD50.811-19.315-263%
P/E RatioN/AN/A-
Revenue065.7M-
Total Cash230M654M35%
Total Debt75M72.4M104%
FUNDAMENTALS RATINGS
NKTX: Fundamental Ratings
NKTX
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NKTX
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXCCX8.37N/A
N/A
Federated Hermes Max-Cap Index C
FARMX21.59N/A
N/A
Fidelity Agricultural Productivity
OSCIX36.03N/A
N/A
Invesco International Small-Mid Com R6
CSEYX23.58N/A
N/A
Columbia Select Global Equity Inst3
TENWX17.30N/A
N/A
Nuveen Emerging Markets Eq Idx W